T2 Biosystems Statistics Share Statistics T2 Biosystems has 28.05M
shares outstanding. The number of shares has increased by 82.51%
in one year.
Shares Outstanding 28.05M Shares Change (YoY) 82.51% Shares Change (QoQ) 33.28% Owned by Institutions (%) 2.34% Shares Floating 11.9M Failed to Deliver (FTD) Shares 51,424 FTD / Avg. Volume 4.26%
Short Selling Information The latest short interest is 834.76K, so undefined% of the outstanding
shares have been sold short.
Short Interest 834.76K Short % of Shares Out n/a Short % of Float 6.69% Short Ratio (days to cover) 1.26
Valuation Ratios The PE ratio is -0.33 and the forward
PE ratio is -0.2.
T2 Biosystems's PEG ratio is
0.
PE Ratio -0.33 Forward PE -0.2 PS Ratio 2.28 Forward PS 0 PB Ratio -0.58 P/FCF Ratio -0.34 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for T2 Biosystems.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.45,
with a Debt / Equity ratio of -1.77.
Current Ratio 0.45 Quick Ratio 0.36 Debt / Equity -1.77 Debt / EBITDA -1.13 Debt / FCF -1.02 Interest Coverage -9.3
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $63.65K Profits Per Employee $-443.16K Employee Count 113 Asset Turnover 0.21 Inventory Turnover 3.19
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -96.5% in the
last 52 weeks. The beta is 0.35, so T2 Biosystems's
price volatility has been higher than the market average.
Beta 0.35 52-Week Price Change -96.5% 50-Day Moving Average 0.15 200-Day Moving Average 1.79 Relative Strength Index (RSI) 45.24 Average Volume (20 Days) 1,206,863
Income Statement In the last 12 months, T2 Biosystems had revenue of 7.19M
and earned -50.08M
in profits. Earnings per share was -19.19.
Revenue 7.19M Gross Profit -8.17M Operating Income -49.66M Net Income -50.08M EBITDA -43.88M EBIT -44.73M Earnings Per Share (EPS) -19.19
Full Income Statement Balance Sheet The company has 15.69M in cash and 49.5M in
debt, giving a net cash position of -33.81M.
Cash & Cash Equivalents 15.69M Total Debt 49.5M Net Cash -33.81M Retained Earnings -584.3M Total Assets 18.08M Working Capital -14.65M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -48.14M
and capital expenditures -192K, giving a free cash flow of -48.33M.
Operating Cash Flow -48.14M Capital Expenditures -192K Free Cash Flow -48.33M FCF Per Share -18.52
Full Cash Flow Statement Margins Gross margin is -113.58%, with operating and profit margins of -690.45% and -696.19%.
Gross Margin -113.58% Operating Margin -690.45% Pretax Margin -696.19% Profit Margin -696.19% EBITDA Margin -609.97% EBIT Margin -690.45% FCF Margin -671.88%
Dividends & Yields TTOO does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for TTOO is $5,
which is 4900% higher than the current price. The consensus rating is "Hold".
Price Target $5 Price Target Difference 4900% Analyst Consensus Hold Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Oct 13, 2023. It was a
backward
split with a ratio of 1:100.
Last Split Date Oct 13, 2023 Split Type backward Split Ratio 1:100
Scores Altman Z-Score -55.51 Piotroski F-Score 3
